SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001019687-16-005177
Filing Date
2016-02-16
Accepted
2016-02-12 18:41:38
Documents
1
Group Members
LVP GP I, LLCLVP GP II, LLCLVP GP III, LLCLVP III ASSOCIATES, L.P.LVP III PARTNERS, L.P.LVP LIFE SCIENCE VENTURES I, L.P.LVP LIFE SCIENCE VENTURES II, L.P.LVP LIFE SCIENCE VENTURES III, L.P. ('LVP III')LVPMC, LLCPATRICK F. LATTERELL

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT lvp-ono_13ga1.htm SC 13G/A 152041
  Complete submission text file 0001019687-16-005177.txt   154009
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Subject) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87757 | Film No.: 161421811
SIC: 2834 Pharmaceutical Preparations

Mailing Address 455 MARKET ST., SUITE 2220 SAN FRANCISCO CA 94105-2446
Business Address 455 MARKET ST., SUITE 2220 SAN FRANCISCO CA 94105-2446 415-399-9880
LVP LIFE SCIENCE VENTURES III L.P. (Filed by) CIK: 0001332654 (see all company filings)

IRS No.: 203061469 | Fiscal Year End: 1231
Type: SC 13G/A